This investment is expected to strengthen Orano Med further and allow the company to expedite its pipeline development, leveraging its lead-212-based therapies discovery and development capabilities.

"We are excited to expand this relationship with Orano Med, representing the bold ambition and high synergy of both groups to build the largest radiotherapy pipeline in our space today. Both ...

Molecular Partners and Orano Med anticipate initiating first-in-human ... directly being applied to the next candidates in our RDT pipeline.” “We are very pleased with the results of MP0712 ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design, and clinical ...

Sanofi and Orano Med have announced a new partnership aimed at accelerating ... the Orano Group subsidiary and allow the company to accelerate the development of its pipeline, “leveraging its ...

The new entity, which will operate under the Orano Med brand, will be focused on discovering ... company to accelerate the development of its pipeline, leveraging its unique capabilities in ...

Sanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design, and clinical ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design, and clinical ...